U.S. BioDefense Seeks To Manufacture Roche’s Tamiflu
This article was originally published in The Pink Sheet Daily
Executive Summary
Department of Defense contractor says details of how Roche will sublicense manufacturing responsibilities for the antiviral remain undecided.